HighVista Strategies »

Alcon shares owned by HighVista Strategies

Quarter-by-quarter ownership of Alcon (ALC) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Alcon

Tip: Access up to 7 years of quarterly data

All positions including Alcon held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alcon by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $466k 7.9k 59.26
2025-06-30 $430k 6.1k 70.20

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Alcon

Vanguard Group
UBS Group
FMR
Reed Conner & Birdwell
Bank of New York Mellon
Zurcher Kantonalbank
Ako Capital
Select Equity
SIH Partners, L
Harding Loevner
Franklin Resources
Vontobel Holding
T. Rowe Price Investment Management
Amundi
Pictet Asset Management Holding SA

View all funds holding Alcon